Enhancer ID: | E_01_0686 |
Species: | human |
Position : | chr16:50739227-50741227 |
Biosample name: | |
Experiment class : | High+Lowthroughput |
Enhancer type: | Enhancer |
Disease: | Rheumatoid arthritis |
Pubmed ID: | 30285829 |
Enhancer experiment: | Immunohistochemistry (IHC),Immunofluorescence (IF) staining,RT-PCR,Western blot,ELISA,Cell proliferation assay,y flow cytometry |
Enhancer experiment description: | Via its regulation of NF-?B activation, CYLD may be involved in the pathogenesis of synovial inflammation in RA as well as in the pro-inflammatory effects and hyperproliferation of RA-FLSs. CYLD may therefore provide a potential target for the treatment of RA. |
Target gene : | CYLD |
Strong evidence: | qRT-PCR,qPCR,ChIP,3C |
Less strong evidence: | RNA-Seq |
Target gene experiment description: | Via its regulation of NF-?B activation, CYLD may be involved in the pathogenesis of synovial inflammation in RA as well as in the pro-inflammatory effects and hyperproliferation of RA-FLSs. CYLD may therefore provide a potential target for the treatment of RA. |
TF name : | -- |
TF experiment: | Immunohistochemistry (IHC),Immunofluorescence (IF) staining,RT-PCR,Western blot,ELISA,Cell proliferation assay,y flow cytometry |
TF experiment description: | Via its regulation of NF-?B activation, CYLD may be involved in the pathogenesis of synovial inflammation in RA as well as in the pro-inflammatory effects and hyperproliferation of RA-FLSs. CYLD may therefore provide a potential target for the treatment of RA. |
Enhancer function : | Via its regulation of NF-?B activation, CYLD may be involved in the pathogenesis of synovial inflammation in RA as well as in the pro-inflammatory effects and hyperproliferation of RA-FLSs. CYLD may therefore provide a potential target for the treatment of RA. |
Enhancer function experiment: | Immunohistochemical staining |
Enhancer function experiment description: |
Via its regulation of NF-?B activation, CYLD may be involved in the pathogenesis of synovial inflammation in RA as well as in the pro-inflammatory effects and hyperproliferation of RA-FLSs. CYLD may therefore provide a potential target for the treatment of RA. |
SNP ID: | -- |
GeneName | Pathway Name | Source | Gene Number |
---|